WILMINGTON, Del., May 17, 2023 /PRNewswire/ -- Wisner Baum managing partner R. Brent Wisner will be co-lead trial counsel in the Zantac (Ranitidine) Products Liability litigation (Civil Action No.

Delaware's highest court said on Tuesday it will hear an appeal by GSK GSK.L and other drug makers seeking to end more than 70,000 lawsuits claiming discontinued heartburn drug Zantac caused cancer.

June 10 (Reuters) - GSK (GSK.L), opens new tab and other drugmakers on Monday asked a Delaware court for permission to appeal a ruling allowing more than 70,000 lawsuits claiming that heartburn drug ...

GSK (NYSE:GSK) stock was up 3% in afternoon trading Tuesday in the wake of a ruling by a Delaware court on whether certain evidence should be allowed in an ongoing case over the safety of its recalled ...

A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer. The ...

(Reuters) -A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause ...

After settlements with Zantac cancer victims in California, litigants prepare for next phase in the litigation involving over 70,000 cases The FDA pulled Zantac because it contained a potent ...

Defendants in Delaware's Zantac litigation have asked the state Supreme Court to review a Superior Court ruling that allowed testimony from plaintiffs' experts, by claiming that the decision placed ...

Jurors in Chicago's Cook County Circuit Court sided with drug manufacturers, but more trials are planned in Illinois, California and Pennsylvania. Drugmakers have appealed a judge's refusal to toss 10 ...

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...